Allergan Biocell Textured Breast Implant Lawsuits To Be Selected For Bellwether Trial Discovery in August 2024
Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
Breast Implant Squamous Cell Carcinoma Rate Appears to Be Very Low: Study Researchers said there were too few cases of breast implant SCC to determine of the condition was actually associated with the implants themselves. April 26, 2023 Irvin Jackson Add Your Comments Amid increasing concerns about a potential link between breast implants and squamous cell cancer, the findings of a new study suggest the rate of such cancers among women with breast implants still appear to be very low. Columbia University researchers indicating the number of breast implant squamous cell carcinoma (SCC) cases is currently too low to determine whether the condition is actually linked to the implants or not. Their findings were posted on April 19 in JAMA Surgery. Concerns about the risk of cancer from certain types of breast implants first emerged several years ago, when the FDA issued an Allergan Biocell implants recall in 2019, after determining that the textured implant surface design was linked to nearly all known cases of breast implant-associated anaplastic large-cell lymphoma (BIA-ALCL), which is a rare form of non-Hodgins lymphoma that has been diagnosed in the tissue surrounding some breast implants. Since that recall, more than 1,000 Allergan breast implant cancer lawsuits have been filed each raising similar allegations that Allergan sold unreasonably dangerous and defective textured implants, without warning women about the potential risk of ALCL. Learn More About Breast Implant Lawsuits Women may face a risk of Anaplastic Large Cell Lymphoma (ALCL) from certain breast implants. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Learn More About Breast Implant Lawsuits Women may face a risk of Anaplastic Large Cell Lymphoma (ALCL) from certain breast implants. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Breast Implant SCC Warnings More recently, concerns were further increased when the U.S. Food and Drug Administration (FDA) issued a breast implant squamous cell carcinoma warning in September 2022, announcing it was investigating a potential link between cases of skin cancer and breast implants detailed in post-marketing reports. Last month, the agency updated that warning, announcing the creation of a registry to track reports of SCC among breast implant recipients. However this latest research, a cohort study which looked at women who underwent cancer-directed mastectomy with breast implant reconstruction between 2000 and 2018 was unable to determine if there was an association between the implants and SCC. Few Cases of Breast Implant SCC Reported After looking at data on nearly 57,000 women, Columbia University researchers were only able to identify one case of breast SCC, which occurred 52 months after the reconstruction surgery. “The incidence rate of SCC after implant-based reconstruction in this analysis was extremely low,” the researchers concluded. “Breast implant-associated SCC has been identified in case reports, with long latency periods from initial implant. Fewer than 20 cases have been reported, and, to our knowledge, no epidemiologic studies have explored the association with implants.” The researchers recommended patients with breast cancer who are eligible for mastectomy and reconstructive surgery be counseled on the risks and benefits of receiving breast implants, but the researchers said they did not believe women should be dissuaded from undergoing the procedure due to risks of breast implant SCC. Squamous cell carcinoma is the second most common form of skin cancer, which causes abnormal squamous cell growth. It often appears as red, scaly patches, sores, and thickened wart-like skin which can bleed, itch, crack and crust over. It can often be effectively treated if caught early, but can be disfiguring and deadly if diagnosis and treatment are delayed. An estimated 1.8 million SCC cases are diagnosed each year, and the incidence rate has doubled over the last 30 years, health experts warn. Tags: BIA-ALCL, Breast Implant, Breast Implant Cancer, Squamous Cell Carcinoma More Breast Implant Lawsuit Stories Breast Implants After Mastectomy May Increase Risk of ALCL for Some Women: Study June 30, 2025 Study Finds Rising Breast Cancer Rates Among Young Women October 14, 2024 Allergan Biocell Textured Breast Implant Lawsuits To Be Selected For Bellwether Trial Discovery in August 2024 June 14, 2024 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermPhoneThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Oxbryta Settlement Discussions in Class Action Lawsuits Set for Sept. 2025 (Posted: yesterday) A mediator has been appointed to oversee settlement discussions between parties involved in an Oxbryta class action lawsuit, which claims the recalled drug endangered sickle cell disease patients. MORE ABOUT: OXBRYTA LAWSUITWrongful Death Lawsuit Links Oxbryta Side Effects to Deadly Vaso-Occlusive Crises (06/05/2025)Oxbryta Recall Lawsuit Alleges Sickle Cell Drug Increased Frequency of Dangerous VOCs (05/23/2025)First Oxbryta Lawsuit Set for Trial in August 2027, Over Recalled Sickle Cell Drug Risks (05/09/2025) Lawsuit Indicates Biozorb Side Effects Left Woman With Chronic Pain, Disfiguring Injuries (Posted: 2 days ago) A BioZorb side effects lawsuit indicates that a woman is suffering chronic pain and soreness after the tissue marker implant failed to absorb into her body as advertised. MORE ABOUT: BIOZORB LAWSUITBioZorb Implant Removal Surgery: What Women Need To Know When the Device Fails To Dissolve (06/30/2025)Lawsuit Claims Biozorb Implant Penetrated Skin, Causing Massive Infection (06/04/2025)Breast Cancer Survivors File BioZorb Tissue Marker Lawsuit After Implant Fails (05/20/2025) Second Wave of Valsartan Cancer Lawsuits To Be Ready for Bellwether Trials by January 2026 (Posted: 2 days ago) A new schedule for a second wave of Valsartan cancer lawsuit bellwether trials hopes to have a case ready to go before a jury by January 2026. MORE ABOUT: VALSARTAN LAWSUITCourt Outlines Valsartan Lawsuits Trial Schedule for “Wave 2” Bellwether Cases (05/28/2025)Order Requires Valsartan Recall Lawsuits To Provide Product Identification for Specific Generic Drug Makers Named (03/27/2025)Deadlines Leading to First Valsartan Bellwether Trial on Sept. 8, 2025 Outlined by Special Master (03/04/2025)
Allergan Biocell Textured Breast Implant Lawsuits To Be Selected For Bellwether Trial Discovery in August 2024 June 14, 2024
Oxbryta Settlement Discussions in Class Action Lawsuits Set for Sept. 2025 (Posted: yesterday) A mediator has been appointed to oversee settlement discussions between parties involved in an Oxbryta class action lawsuit, which claims the recalled drug endangered sickle cell disease patients. MORE ABOUT: OXBRYTA LAWSUITWrongful Death Lawsuit Links Oxbryta Side Effects to Deadly Vaso-Occlusive Crises (06/05/2025)Oxbryta Recall Lawsuit Alleges Sickle Cell Drug Increased Frequency of Dangerous VOCs (05/23/2025)First Oxbryta Lawsuit Set for Trial in August 2027, Over Recalled Sickle Cell Drug Risks (05/09/2025)
Lawsuit Indicates Biozorb Side Effects Left Woman With Chronic Pain, Disfiguring Injuries (Posted: 2 days ago) A BioZorb side effects lawsuit indicates that a woman is suffering chronic pain and soreness after the tissue marker implant failed to absorb into her body as advertised. MORE ABOUT: BIOZORB LAWSUITBioZorb Implant Removal Surgery: What Women Need To Know When the Device Fails To Dissolve (06/30/2025)Lawsuit Claims Biozorb Implant Penetrated Skin, Causing Massive Infection (06/04/2025)Breast Cancer Survivors File BioZorb Tissue Marker Lawsuit After Implant Fails (05/20/2025)
Second Wave of Valsartan Cancer Lawsuits To Be Ready for Bellwether Trials by January 2026 (Posted: 2 days ago) A new schedule for a second wave of Valsartan cancer lawsuit bellwether trials hopes to have a case ready to go before a jury by January 2026. MORE ABOUT: VALSARTAN LAWSUITCourt Outlines Valsartan Lawsuits Trial Schedule for “Wave 2” Bellwether Cases (05/28/2025)Order Requires Valsartan Recall Lawsuits To Provide Product Identification for Specific Generic Drug Makers Named (03/27/2025)Deadlines Leading to First Valsartan Bellwether Trial on Sept. 8, 2025 Outlined by Special Master (03/04/2025)